SPRITZENVORRICHTUNGEN
European patent · EP3341056 · In force
Register entry
- Publication number
- EP3341056
- Application number
- EP16713695
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Mar 17, 2016
- Published
- Jul 4, 2018
- Granted
- Jun 15, 2022
- Protection ends at the latest
- Mar 16, 2036
- Next annual fee due
- Mar 31, 2027
- IPC classes
- A61M 5/315 (2006.01)A61M 5/32 (2006.01)A61M 5/31 (2006.01)
- Priority
- US 201562209272 P 24.08.2015US 201562235984 P 01.10.2015
- PCT application
- PCT/US2016/022956 17.03.2016
- PCT publication
- WO2017/034618 02.03.2017
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Apr 1, 2026
Change
Published in Swissreg on 01.04.2026
- Apr 1, 2025
Change
Published in Swissreg on 01.04.2025
- May 14, 2024
Address changed
- Owner
- Adamis Pharmaceuticals Corporation, 11682 El Camino Real, Suite 300, San Diego, CA 92130, USA → DMK Pharmaceuticals Corporation, 11682 El Camino Real, Suite 300, San Diego, CA 92130, USA
Published in Swissreg on 14.05.2024
- Apr 2, 2024
Change
Published in Swissreg on 02.04.2024
- Jun 9, 2023
Change
Published in Swissreg on 09.06.2023
- Apr 26, 2023
Change
Published in Swissreg on 26.04.2023
- Sep 8, 2022
Agent entered
- Representative
- Novagraaf International SA, Chemin de l'Echo 3, 1213 Onex
Published in Swissreg on 08.09.2022
- Jun 15, 2022
Granted
Published in Swissreg on 15.06.2022
Parties
Inventor
San Diego, CA 92130, US
San Diego, CA 92130, US
St. Paul, MN 55133-3427, US
San Diego, CA 92130, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.